Table 1: Total Pipeline Products for Reflux Esophagitis (Gastroesophageal Reflux Disease)
Table 2: Number of Products under Development by Companies
Table 3: Late stage Therapeutic Products
Table 4: Mid stage Therapeutic Products
Table 5: Early stage Therapeutic Products
Table 6: Pre-clinical stage Therapeutic Products
Table 7: Discovery stage Therapeutic Products
Table 8: Pipeline Analysis by Route of Administration
Table 9: Pipeline Analysis by Stage and Route of Administration
Table 10: Pipeline Analysis by Molecule Type
Table 11: Pipeline Analysis by Stage and Molecule Type
Table 12: Pipeline Analysis by Target
Table 13: Dormant / Discontinued Products
Table 14: Company Profile

LIST OF FIGURE

Figure 1: Total Pipeline Products for Reflux Esophagitis (Gastroesophageal Reflux Disease)
Figure 2: Late stage Therapeutic Products
Figure 3: Mid stage Therapeutic Products
Figure 4: Early stage Therapeutic Products
Figure 5: Pre-clinical stage Therapeutic Products
Figure 6: Discovery stage Therapeutic Products
Figure 7: Pipeline Analysis by Route of Administration
Figure 8: Pipeline Analysis by Stage and Route of Administration
Figure 9: Pipeline Analysis by Molecule Type
Figure 10: Pipeline Analysis by Stage and Molecule Type
Figure 11: Pipeline Analysis by Target
Figure 12: Dormant / Discontinued Products